Financials

News Discussions Technicals Seasonals

NSB fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD operating, investing, and financing activities

NSB free cash flow for H1 25 is -460.78 k AUD. For 2024, NSB free cash flow was 42.43 k AUD and operating cash flow was 44.25 k AUD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: AUD

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—